Importantly, XCT790, by decreasing ERRα expression, produced the same up-regulatory effects on the expression of GPT, SLC1A5 and GLS1 genes in all three ACC cell lines [Figure 10]. The gene discussed is ESRRA; the disease is adrenal cortex carcinoma.